Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;20(3):957-958.
doi: 10.1007/s11739-024-03785-3. Epub 2024 Oct 21.

Towards a sustainable pricing of pharmaceutical goods

Rachele Ciccocioppo  1 , Natividad Cuende  2
Affiliations

Towards a sustainable pricing of pharmaceutical goods

Rachele Ciccocioppo et al. Intern Emerg Med. 2025 Apr.
No abstract available

Keywords: Drug pricing; Health policy; Social responsibility.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: Prof. Rachele Ciccocioppo received grants from Takeda, Abbvie, Galapagos, Pfizer for the following: honoraria for speaking at symposia, financial support for attending symposia, consultation, position on advisory board; these professional activities do not have any potential conflict of interest that may be directly or indirectly relevant to this article. Prof. Natividad Cuende has no conflict of interest to declare. Human and animal rights: This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent: For this type of study formal consent is not required.

References

    1. Garattini L, Freemantle N, Nobili A, Mannucci PM (2023) Conceptualizing a model for European health systems: the institutional framework. Internal Emerg Med 18:1213–1215 - DOI
    1. Everts M, Drew M (2024) Successfully navigating the valley of death: the importance of accelerators to support academic drug discovery and development. Exp Opin Drug Discov 19:253–258. https://doi.org/10.1080/17460441.2023.2284824 - DOI
    1. Rosenberg N, Stolwijk NN, van den Berg S, Heus JJ, van der Wel V, van Gelder T, Bosch AM, de Visser SJ, Hollak CEM (2023) Development of medicines for rare diseases and inborn errors of metabolism: toward novel public-private partnerships. J Inherit Metab Dis. https://doi.org/10.1002/jimd.12605 - DOI - PubMed
    1. Thielen FW, Heine RJSD, van den Berg S, ten Ham RMT, Uyl-de Groot CA (2022) Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma. Cytotherapy 24:1245–1258 - DOI - PubMed
    1. Garattini L, Freemantle N, Nobili A, Mannucci PM (2023) A European national health and social service model: a few rules of the game. Intern Emerg Med 18:1583–1585 - DOI - PubMed

LinkOut - more resources